Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome

Effective treatment options are still scarce for metastatic triple-negative breast cancers. An increasing interest in the mutational landscape of this disease will facilitate novel therapeutic strategies in a variety of cancers. Here we report the case of a 38-year-old female patient who developed m...

Descripción completa

Detalles Bibliográficos
Autores principales: Pircher, Magdalena, Winder, Thomas, Trojan, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077504/
https://www.ncbi.nlm.nih.gov/pubmed/33976643
http://dx.doi.org/10.1159/000513905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077504/
https://www.ncbi.nlm.nih.gov/pubmed/33976643
http://dx.doi.org/10.1159/000513905

Ejemplares similares